文献速递基础与转化研究组学、生物样本库与精准医学

CD39+CD49a+CD103+细胞毒性组织驻留NK细胞浸润并控制小鼠实体上皮肿瘤生长

CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice.
PubMed 文献 · Sci Transl Med · 2026-05-06

研究采用多组学方法表征人组织驻留NK细胞,鉴定出以CD39为标志的细胞毒性trNK(ctrNK)亚群。该亚群对肿瘤靶细胞杀伤活性更强、浸润实体瘤微环境能力更高,并在小鼠体内控制实体瘤生长优于常规活化外周NK细胞。其杀伤和浸润功能部分由CD103表达及对肿瘤靶标的亲和力赋予,且可在体外分化扩增,为实体瘤过继细胞治疗提供潜在平台。

要点

  • CD39可标识高细胞毒性组织驻留NK细胞亚群。
  • ctrNK细胞浸润实体瘤和控瘤能力优于外周NK细胞。
  • CD103表达与肿瘤靶标亲和力部分介导ctrNK功能。

核心结论

  • CD39+CD49a+CD103+ ctrNK细胞具有 superior 杀伤、浸润和体内控瘤能力,可在体外分化扩增,为实体瘤过继细胞治疗提供潜在平台。

研究设计与样本

  • 采用多组学方法对人组织驻留NK细胞进行分子表征,并在小鼠体内评估ctrNK细胞对实体瘤生长的控制。

主要发现

  • ctrNK细胞对肿瘤靶细胞的细胞溶解活性优于常规活化外周NK细胞。
  • ctrNK细胞浸润实体瘤微环境的能力增强。
  • ctrNK细胞在小鼠体内控制实体瘤生长的能力增强。
  • ctrNK细胞的杀伤和浸润功能部分由CD103表达及对肿瘤靶标的亲和力所赋予。

临床怎么用

  • ctrNK细胞可在体外分化扩增,提示其可作为实体瘤过继细胞治疗的潜在细胞来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human tissue-resident natural killer (NK) cells (trNK cells), broadly defined by markers of tissue residency, such as CD49a [integrin α1 (ITGA1)] and CD103 [integrin αE (ITGAE)], are increasingly recognized for their immunoregulatory role in host control of infection, malignancy, and autoimmunity. Although the importance of transforming growth factor-β in trNK cell differentiation has been demonstrated, the context in which the differentiation of CD49a+CD103+ trNK cells occurs can result in either an immunosuppressive phenotype (e.g., decidual NK cells) or a highly cytotoxic one (e.g., some tumor trNK subsets). To understand this dichotomy better, we used a multiomic approach to molecularly characterize these cells. We identified a cytotoxic trNK (ctrNK) cell population, characterized by the expression of CD39. These ctrNK cells exhibited superior cytolytic activity against tumor target cells, enhanced capacity to infiltrate into solid tumor microenvironments, and augmented ability to control solid tumor growth in vivo compared with conventionally activated peripheral NK cells. This heightened cytolytic and infiltrative functionality of ctrNK cells appeared to be conferred, in part, by the expression of CD103 and by avidity for tumor targets. Because adoptive immune cell therapy of solid tumor malignancies has been challenged by the inefficiency of ex vivo expanded immune cells to infiltrate immunosuppressive solid tumor microenvironments, our observations that ctrNK cells can be differentiated and expanded ex vivo present a potential platform for adoptive cell therapy of solid tumor malignancies.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Horowitz NB, Mohammad IA, Shin JH, et al. CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice. Sci Transl Med. 2026. PMID: 42090477. doi:10.1126/scitranslmed.adw5567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。